Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation

NCT07722832 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DEVICE: Quitoxil®
DRUG: Nicotine Replacement Therapies

Sponsor

KLAVA Innovation